These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38329441)

  • 1. Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology.
    Li M; Zhao Y; Li H; Kang S; Deng X; Sheng M
    Aging (Albany NY); 2024 Feb; 16(3):2848-2865. PubMed ID: 38329441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway.
    Xu Y; Fang R; Shao J; Cai Z
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34036307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated component identification, network pharmacology, and experimental verification revealed mechanism of Dendrobium officinale Kimura et Migo against lung cancer.
    Zhao Y; Zhu S; Li Y; Niu X; Shang G; Zhou X; Yin J; Bao B; Cao Y; Cheng F; Li Z; Wang R; Yao W
    J Pharm Biomed Anal; 2024 Jun; 243():116077. PubMed ID: 38460276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erianin inhibits human lung cancer cell growth via PI3K/Akt/mTOR pathway in vitro and in vivo.
    Zhang HQ; Xie XF; Li GM; Chen JR; Li MT; Xu X; Xiong QY; Chen GR; Yin YP; Peng F; Chen Y; Peng C
    Phytother Res; 2021 Aug; 35(8):4511-4525. PubMed ID: 34236105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.
    Yang L; Hu Y; Zhou G; Chen Q; Song Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erianin inhibits the progression of triple-negative breast cancer by suppressing SRC-mediated cholesterol metabolism.
    Li M; Kang S; Deng X; Li H; Zhao Y; Tang W; Sheng M
    Cancer Cell Int; 2024 May; 24(1):166. PubMed ID: 38734640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer.
    Zhao M; Fu L; Xu P; Wang T; Li P
    Drug Des Devel Ther; 2023; 17():901-917. PubMed ID: 36998242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology.
    Chu M; Meng T; Zhou Y; Jin L; Dai Q; Ma L; Chen H
    Medicine (Baltimore); 2023 Sep; 102(35):e34763. PubMed ID: 37657065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin suppresses metastasis of triple-negative breast cancer cells by modulating EMT signaling pathways: An integrated study of bioinformatics analysis.
    Chen Z; Lu P; Li M; Zhang Q; He T; Gan L
    Medicine (Baltimore); 2024 Feb; 103(8):e37264. PubMed ID: 38394486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway.
    Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J
    Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling.
    Cheng W; Liu D; Guo M; Li H; Wang Q
    Drug Dev Res; 2022 Aug; 83(5):1138-1151. PubMed ID: 35426453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma.
    Zhou K; Lu D; You J; Liu T; Sun J; Lu Y; Pan J; Li Y; Liu C
    J Ethnopharmacol; 2022 Nov; 298():115624. PubMed ID: 35970314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology.
    Wu T; Xiang M; Li Y; Gao Y; Teng D; Sun M; Guo W; Zhou Y
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):341. PubMed ID: 38179762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity.
    Yang A; Li MY; Zhang ZH; Wang JY; Xing Y; Ri M; Jin CH; Xu GH; Piao LX; Jin HL; Zuo HX; Ma J; Jin X
    J Ethnopharmacol; 2021 Jun; 273():113598. PubMed ID: 33220359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of oroxyli semen against triple-negative breast cancer verified by bioinformatics and in vitro experiments.
    Chen L; Yang A; Li Y; Liu X; Jiang W; Hu K
    Medicine (Baltimore); 2023 Sep; 102(37):e34835. PubMed ID: 37713894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology: Ixeris sonchifolia Induces Hepatocellular Carcinoma Apoptosis via the PI3K/AKT Pathway.
    Liu BJ; Guan YY; Qiao LX; Zhang JM; Li AJ; Yang PX; Gao YX; Chen DX; Wang CX; Wu J
    J Ethnopharmacol; 2024 Jun; 327():117994. PubMed ID: 38437889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
    Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.